RGNX Operating Expenses

Regenxbio Inc · Operating Expenses

RGNX logo

RGNX Operating Expenses

Latest reported$258.76M
RGNX TTM Operating Expenses ($6.97M → $258.76M)
High-resolution chart · PNG

RGNX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
258,758,000
256,567,000
251,335,000
235,554,000
289,124,000
277,303,000
272,775,000
277,054,000
284,652,000
304,560,000
316,822,000
322,612,000
325,589,000
324,210,000
321,055,000
306,723,000
296,276,000
278,487,000
258,534,000
261,372,000
254,953,000
244,226,000
238,086,000
221,548,000
202,053,000
191,164,000
175,990,000
163,173,000
142,585,000
129,568,000
120,765,000
104,301,000
98,749,000
89,241,000
84,569,000
87,384,000
84,180,000
80,708,000
68,970,000
56,179,000
45,647,000
36,167,000
29,203,000
23,355,000
17,276,000
10,929,000
6,965,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.